[1] |
Angulo I, Vadas O, Garçon F, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage[J]. Science, 2013, 342(6160):866-871.
doi: 10.1126/science.1243292
pmid: 24136356
|
[2] |
唐文静, 王薇, 罗颖, 等. PIK3CD基因突变致PI3Kδ过度活化综合征临床及免疫学特点分析[J]. 中华儿科杂志, 2017, 55(1):19-24.
|
[3] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
doi: 10.1038/gim.2015.30
pmid: 25741868
|
[4] |
Teranishi H, Ishimura M, Koga Y, et al. Activated phosphoinositide 3-kinase δ syndrome presenting with gut-associated T-cell lymphoproliferative disease[J]. Rinsho Ketsueki, 2017, 58(1):20-25.
|
[5] |
Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study[J]. J Allergy Clin Immunol, 2017, 139(2):597-606.
doi: S0091-6749(16)30623-6
pmid: 27555459
|
[6] |
Sullivan KE, Conrad M, Kelsen JR. Very early-onset inflammatory bowel disease: an integrated approach[J]. Curr Opin Allergy Clin Immunol, 2018, 18(6):459-469.
doi: 10.1097/ACI.0000000000000484
URL
|
[7] |
Elkaim E, Neven B, Bruneau J, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study[J]. J Allergy Clin Immunol, 2016, 138(1):210-218.
doi: 10.1016/j.jaci.2016.03.022
URL
|
[8] |
Dulau Florea AE, Braylan RC, Schafernak KT, et al. Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD[J]. J Allergy Clin Immunol, 2017, 139(3):1032-1035.
doi: S0091-6749(16)31052-1
pmid: 27697496
|
[9] |
Sinclair LV, Finlay D, Feijoo C, et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking[J]. Nat Immunol, 2008, 9(5):513-521.
doi: 10.1038/ni.1603
pmid: 18391955
|
[10] |
Dornan GL, Siempelkamp BD, Jenkins ML, et al. Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1[J]. Proc Natl Acad Sci U S A, 2017, 114(8):1982-1987.
doi: 10.1073/pnas.1617244114
URL
|
[11] |
Burke JE, Vadas O, Berndt A, et al. Dynamics of the phosphoinositide 3-kinase p110δ interaction with p85α and membranes reveals aspects of regulation distinct from p110α[J]. Structure, 2011, 19(8):1127-1137.
doi: 10.1016/j.str.2011.06.003
pmid: 21827948
|
[12] |
Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency[J]. Nat Immunol, 2014, 15(1):88-97.
doi: 10.1038/ni.2771
URL
|